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In response to DNA double-strand breaks (DSBs),
H2AX is rapidly phosphorylated at Ser139 to promote
DSB repair. Here we show that H2AX is rapidly stabi-
lized in response to DSBs to efficiently generate
gH2AX foci. This mechanism operated even in quies-
cent cells that barely expressed H2AX. H2AX stabili-
zation resulted from the inhibition of proteasome-
mediated degradation. Synthesized H2AX ordinarily
underwent degradation through poly-ubiquitination
mediated by the E3 ligase HUWE1; however, H2AX
ubiquitination was transiently halted upon DSB for-
mation. Such rapid H2AX stabilization by DSBs was
associated with chromatin incorporation of H2AX
and halting of its poly-ubiquitination mediated by
the ATM kinase, the sirtuin protein SIRT6, and the
chromatin remodeler SNF2H. H2AX Ser139, the
ATM phosphorylation site, was essential for H2AX
stabilization upon DSB formation. Our results reveal
a pathway controlled by ATM, SIRT6, and SNF2H to
block HUWE1, which stabilizes H2AX and induces
its incorporation into chromatin only when cells are
damaged.
INTRODUCTION
In response to DNA double-strand breaks (DSBs), ATM is acti-
vated and recruited to DSB sites, where it phosphorylates
H2AX at Ser139 to generate gH2AX foci (Stucki and Jackson,
2006; Bonner et al., 2008). ATR and DNA-PK also are implicated2728 Cell Reports 13, 2728–2740, December 29, 2015 ª2015 The Auin H2AX phosphorylation (Stucki and Jackson, 2006; Bonner
et al., 2008). This phosphorylation, which promotes DSB repair
by non-homologous end joining and homologous recombina-
tion, is required for genome stability (Bassing and Alt, 2004; Fer-
nandez-Capetillo et al., 2004). MDC1 rapidly binds to gH2AX,
further promoting recruitment of the MRN complex and ATM
and subsequent H2AX phosphorylation, resulting in the amplifi-
cation of DNA damage signals. Within a few minutes after expo-
sure to ionizing radiation, gH2AX is initially present in small foci,
but subsequently spreads to an 30-Mb stretch around lesions;
the resultant large foci peak 30min after damage (Rogakou et al.,
1999). gH2AX serves as a platform for DNA repair enzymes and
chromatin-remodeling complexes, and it plays a critical role in
the cellular response to DSBs (van Attikum and Gasser, 2009;
Pinder et al., 2013).
Ubiquitination of H2AX is involved in the effective recruitment
of many DNA repair-associated factors (Pinder et al., 2013). At
least two types of ubiquitination are involved in this process:
mono-ubiquitination at K119/K120 sites (Facchino et al., 2010;
Ismail et al., 2010; Bentley et al., 2011; Ginjala et al., 2011; Wu
et al., 2011) and poly-ubiquitination at K13/K15 sites (Gatti
et al., 2012; Mattiroli et al., 2012). Approximately 5%–15% of
H2A is constitutively mono-ubiquitinated at K119 or K120 in a re-
action catalyzed by RNF2-BMI1; this modification is required for
ATM recruitment to DSB sites (Pinder et al., 2013). H2AX at DSB
sites is poly-ubiquitinated at K13 or K15, mediated by RNF168 in
an MDC1-, NBS1-, and RNF8-dependent manner (van Attikum
and Gasser, 2009). Together with RNF8, RNF168 catalyzes the
formation of non-proteolytic K63-linked ubiquitin chains, which
are involved in the recruitment of BRCA1 and 53BP1 (Doil
et al., 2009; Mattiroli et al., 2012), in which 53BP1 directly recog-
nizes ubiquitinated H2A/H2AX at the K15 site (Fradet-Turcotte
et al., 2013).thors
The sirtuin protein SIRT6, which possesses multiple functions
including aging regulation (Martinez-Pastor and Mostoslavsky,
2012; Jia et al., 2012; Gertler and Cohen, 2013), mediates DSB
repair in multiple steps (McCord et al., 2009; Kaidi et al., 2010;
Mao et al., 2011), and it recruits SNF2H, the catalytic subunit
of ISWI chromatin-remodeling complexes, to promote DSB
repair (Toiber et al., 2013). It was shown recently that SNF2H is
recruited to the damaged site prior to gH2AX induction (Min
et al., 2014). This implies that chromatin remodeling is involved
in the immediate response upon DSB formation for efficient
gH2AX foci formation.
H2AX has been studied primarily in transformed cell lines and
less extensively in untransformed cells. H2AX is stably ex-
pressed in transformed cells; for example, in HeLa and the
SF268 human glioma tumor cell lines, H2AX represents 2%
and 20% of total H2A, respectively (Bonner et al., 2008). Un-
transformed cells contain much lower levels of H2AX under
some conditions (Lal et al., 2009; Atsumi et al., 2011), and the
level of H2AX is often more than two orders of magnitude lower
in resting cells than in actively proliferating cells (Atsumi et al.,
2011). These observations raise questions about the formation
of gH2AX foci and the associated DNA damage response in
resting and untransformed cells.
In this study, we found that H2AX is rapidly turned over under
normal conditions, accounting for the extremely low levels of
H2AX in resting cells. In response to DSBs, H2AX is transiently
stabilized and incorporated into chromatin. Our results show
that the E3 ligase HUWE1 mediates H2AX poly-ubiquitination
and degradation under undamaged conditions, and they show
that ATM and SIRT6/SNF2H collaboratively regulate the rapid
stabilization of H2AX and its incorporation into chromatin upon
DSB formation by blocking HUWE1.
RESULTS
Quiescent Cells Efficiently Express gH2AX in Response
to DSBs
To investigate the DNA damage response of untransformed
quiescent and proliferating cells, we analyzed mouse embryonic
fibroblasts (MEFs). MEFs are capable of proliferating immedi-
ately after ex vivo culture (hereafter referred to as primary
MEFs), whereas they lose their proliferation capability at the
eighth passage (hereafter referred to quiescent MEFs) (Atsumi
et al., 2011). The amount of H2AX decreases with increased pas-
sage number (Atsumi et al., 2011). For subsequent experiments,
we used primary and quiescent MEFs as representative untrans-
formed cycling and quiescent cells, respectively. We exposed
both types of MEFs to a radiomimetic damaging agent, neocar-
zinostatin (NCS), and monitored phosphorylation of H2AX
(gH2AX). Unexpectedly, in response to NCS treatment, quies-
cent MEFs still expressed gH2AX, similar to primary MEFs
(Figure 1A).
To elucidate the response to DSBs in quiescent untrans-
formed cells, we performed immunofluorescence analysis
before and after NCS treatment and compared the levels of
H2AX and gH2AX between quiescent and primary MEFs. As pre-
viously reported (Atsumi et al., 2011), H2AX was detected only in
primary and immortalized MEFs, not quiescent MEFs, prior toCell RepNCS treatment (Figures 1B, 1C, and S1A). Surprisingly, however,
quiescent MEFs were still capable of forming clear gH2AX foci in
response to DSBs (Figure 1B). In quiescent cells, formation of
gH2AX foci was associated with a >60-fold increase in the
amount of H2AX within 1 hr after 100 ng/ml NCS treatment (Fig-
ures 1B and 1C). A similar result was obtained following g-ray
irradiation (Figure S1B). H2AX also accumulated following UV
irradiation and hydroxyurea (HU) treatment in association with
gH2AX induction, although H2AX accumulation was much
slower than that following NCS treatment and g-ray irradiation
(Figure S1C).
H2AX initially appeared in small foci that co-localized exten-
sively with gH2AX foci (at 5 min after NCS treatment) (Figure 1D,
see white arrowheads), indicating that H2AX was preferentially
induced at DSB sites. Such H2AX induction also was observed
in primary and immortalized MEFs (Figure S1A). Together,
these observations suggest that cells possess a mechanism
that allows a massive increase in the amount of H2AX following
DSB formation, thereby enabling efficient formation of gH2AX
foci.
The Amount of H2AX Increases during DSB Repair
We observed elevation of the H2AX level in the chromatin frac-
tion, but not in the nucleoplasm (Figure 2A), supporting the
idea that H2AX upregulation is associated with chromatin incor-
poration and gH2AX foci formation. The H2AX level transiently
increased and then substantially decreased within 6 hr after
NCS treatment, returning to baseline by 24 hr (Figure 2B). Impor-
tantly, in quiescent MEFs, the amount of H2AX after NCS treat-
ment exhibited kinetics essentially identical to those of gH2AX
(Figure 2B). In primary and immortalized MEFs, in which the
background H2AX level was higher than in quiescent MEFs,
H2AX upregulation was similarly associated with gH2AX expres-
sion (Figure 2B). Similar results also were obtained in normal
human fibroblast cells WI-38 (Figure 2C) and in cancer cells (Fig-
ure S2A). Although the cellular H2AX level could slightly change
during the cell cycle, H2AX upregulation upon DSB formation
was not dependent on the cell cycle (Figures S2B and S2C).
Thus, unrepaired DSBs may cause a transient increase in the
amount of H2AX.
To monitor the DNA damage status, we performed comet as-
says (Figure 2D). Quiescent and primary MEFs exhibited similar
kinetics of DNA strand-break formation and repair; prominent
comet tails were seen at 1 hr, but were undetectable at 6 hr after
NCS treatment (Figure 2D). Thus, in quiescent MEFs, the tempo-
ral change in the amount of H2AX correlated well with the levels
of DNA damage, as well as the amount of gH2AX (Figures 2B and
2E). These results suggest that phosphorylation of H2AX at unre-
paired DSB sites is responsible for the transient increase in the
amount of H2AX.
H2AX Is Continuously Degraded by the Proteasome
Pathway
The extremely rapid rise in the level of H2AX following DSB for-
mation implied that the increase resulted from rapid stabilization
of H2AX rather than elevated expression of the H2AX gene.
Consistent with this idea, the level of the H2AX transcript ex-
hibited no significant change, whereas the level of miR34a,orts 13, 2728–2740, December 29, 2015 ª2015 The Authors 2729
Figure 1. H2AX Stabilization by DSBs Results in the Formation of gH2AX Foci
(A) gH2AX response to DSBs in quiescent normal MEFs. The gH2AX response to DSBs in quiescent MEFs (passage 8) was compared with that in primary MEFs
after treatment with 100 ng/ml NCS. N/T, non-treated.
(B) Formation of gH2AX foci mediated by stabilization of H2AX. Levels of H2AX and gH2AX foci in primary and quiescent MEFs at 1 hr after NCS (100 ng/ml)
treatment were compared by immunofluorescence. Scale bars, 10 mm.
(C) H2AX stabilization by DSBs. The dose-dependent effects of NCS were assessed in quiescent MEFs (passage 8) at 1 hr after NCS treatment.
(D) Primary H2AX stabilization at damaged sites. Initial H2AX and gH2AX foci (5 min after damage) were assessed by immunofluorescence and compared with
those at 1 hr. White arrowheads represent gH2AX foci merged with the stabilized H2AX foci. Scale bars, 10 mm.a damage-response target of p53 (Raver-Shapira et al., 2007;
Chang et al., 2007), increased following DSB formation (Fig-
ure 3A). Thus, the rapid increase in the amount of H2AX can be
attributed to the immediate stabilization of H2AX protein in
response to DNA damage. Supporting this idea, H2AX upregula-
tion by DSBs also was observed for exogenously expressed
FLAG-tagged H2AX after NCS treatment (Figure S2D).
To determine whether the mechanism underlying H2AX upre-
gulation involves proteasomal degradation, we investigated the
effects of the proteasome inhibitor MG132 and the E1 ubiquitin
ligase inhibitor PYR41 on quiescent MEFs. Remarkably, the
H2AX level in quiescent MEFs increased more than 60-fold af-
ter MG132 treatment for 12 hr (Figure 3B). Multiple shifted
bands also were detected on the same immunoblots at 1.5 hr
after MG132 treatment (Figure 3B, see red arrowheads), in2730 Cell Reports 13, 2728–2740, December 29, 2015 ª2015 The Auwhich higher molecular weight signals, which were increased
by MG132 treatment and detected by an anti-H2AX antibody,
were identified as poly-ubiquitinated H2AX by cross-immu-
noprecipitation (IP) and immunoblotting (IB) using anti-H2AX
and -ubiquitin antibodies (Figure S3A, see red arrowheads).
H2AX accumulation also was observed following PYR41 treat-
ment (Figure 3B). Thus, H2AX protein is produced continuously;
however, it is normally poly-ubiquitinated and, hence,
degraded by the proteasome pathway. The amount of H2AX
in immortalized MEFs also increased several fold upon treat-
ment with MG132 (Figure 3C). Similar H2AX accumulation
was observed in HeLa cells following treatment with PYR41
(at 1.5 hr) and MG132 (by 12 hr) (Figure 3D). These observa-
tions are consistent with H2AX stabilization by DSBs in HeLa
cells (Figure S2A). Therefore, this type of regulation is notthors
Figure 2. DSBs Induced in Quiescent MEFs Are Repaired by Transient H2AX Stabilization
(A) H2AX stabilization and incorporation into chromatin. Quiescent normal MEFs (passage 8) treated with NCS (100 ng/ml) were fractionated into chromatin and
non-chromatin fractions before and 1.5 and 24 hr after NCS treatment. Histone H3 (H3) and PCNA were used as controls.
(B and C) gH2AX expression in association with transient H2AX stabilization by DSBs. The effect of transiently stabilized H2AXwasmonitored during the decay of
gH2AX in primary, quiescent (passage 8), and immortalizedMEFs after cells were treatedwith NCS (100 ng/ml) (B). Identical H2AX stabilization alsowas observed
in normal human fibroblasts in both actively growing and quiescent states (C).
(D and E) DSBs induced in quiescent cells are repaired in association with transient stabilization of H2AX. The DNA damage repair status in primary and quiescent
normal MEFs was determined by the disappearance of comet tails (D) and the decay of gH2AX foci (E) after cells were treated with NCS (100 ng/ml). Error bars
represent ± SD. Scale bars, 10 mm.limited to quiescent cells, but also operates in H2AX-express-
ing cells, including cancer cells.
In contrast to undamaged cells, NCS-treated cells did not
accumulate additional H2AX and gH2AX when they were simul-
taneously treated with MG132; we observed no difference in
the level of H2AX (Figure 3E, see closed red arrowheads) or
higher molecular weight bands (Figure 3E, see open red arrow-
heads). Therefore, we concluded that H2AX is continuouslyCell Repsubjected to proteasome-mediated degradation, which is in-
hibited following DNA damage, enabling efficient stabilization
of H2AX.
H2AX Ubiquitination Is Mediated by the E3 Ubiquitin
Ligase HUWE1
To identify the E3 ubiquitin ligase that targets H2AX under un-
damaged conditions, we first lysed undamaged HeLa cells andorts 13, 2728–2740, December 29, 2015 ª2015 The Authors 2731
Figure 3. H2AX Stabilization by DSBs Is Due to a Transient Halt in Proteasomal Degradation that Limits H2AX Levels under Normal Cellular
Conditions
(A) H2AX transcript levels do not change in response to DSBs. The H2AX transcript levels were determined in quiescent MEFs (passage 8). The change in the
transcript levels was indicated with normalization to the level before NCS treatment. miR34a, a target of p53 in response to DSBs, was used as a positive control.
Error bars represent ± SD.
(B–D) H2AX accumulates following treatment with the proteasome inhibitor MG132 and the E1 ubiquitin ligase inhibitor PYR41. Quiescent undamaged MEFs
were treated with MG132 and PYR41 and the H2AX status was determined by IB (B). The H2AX accumulation status also was determined in immortalized MEFs
after MG132 treatment (C). Similarly, the H2AX accumulation status was determined in HeLa cells after treatment with MG132 and PYR41 (D). Multiple shifted
bands, indicative of poly-ubiquitination, were detected at higher molecular weights in cells treated with MG132 (red arrowheads and arrows).
(E) A transient halt in H2AX degradation in response to DSBs. As shown in the top panel, the effects of MG132 treatment (for 1 hr) prior to, simultaneous with, and
11 hr after NCS treatment were tested. DMSO, the solvent in which MG132 was dissolved, was added as the non-treatment control. Blue and green arrowheads
indicate poly-ubiquitinated H2AX bands that accumulated following treatment with MG132 prior to and 11 hr after NCS treatment, respectively. Red open ar-
rowheads indicate poly-ubiquitinated H2AX bands that failed to accumulate following simultaneous treatment of NCS and MG132. Red closed arrowheads
indicate H2AX and gH2AX expression following NCS treatment.fractionated them to separate poly-ubiquitinated H2AX from
chromatin-incorporated H2AX (Figure 4A). H2AX was observed
in the pellet fraction, but IP of the supernatant fraction using an
anti-H2AX antibody revealed other signals at around 100 kDa
(Figures 4A and S3B). Based on its detection by cross-IP and
-IB with anti-H2AX and -ubiquitin antibodies and the competition
assay, we identified this signal as poly-ubiquitinated H2AX (Fig-
ures 4B and S3C). The majority of this signal was detected in the
supernatant fraction, whereas non-ubiquitinated H2AX pelleted
with histone H3 (Figure S3B). Thus, this fractionation approach
efficiently separated poly-ubiquitinated H2AX from non-ubiquiti-
nated H2AX that was incorporated into chromatin.
Next we immunoprecipitated poly-ubiquitinated H2AX with an
anti-H2AX antibody, and we analyzed the immunoprecipitated
material by two-dimensional image-converted analysis of liquid
chromatography and mass spectrometry (2DICAL) (Fukawa
et al., 2012; Ono et al., 2006). In this analysis, 1,717 signals
were over 2-fold higher in immunoprecipitates obtained using2732 Cell Reports 13, 2728–2740, December 29, 2015 ª2015 The Auan anti-H2AX antibody than in those obtained using non-immune
IgG. Among the enriched proteins, along with H2AX and ubiqui-
tin, the E3 ligase HUWE1 was detected (also known as Arf-BP1,
Mule, and Lasu1). The interaction between HUWE1 and poly-
ubiquitinated H2AX revealed by 2DICAL (Figure 4C) was
confirmed by IB (Figure 4D). To determine whether HUWE1 me-
diates H2AX degradation under undamaged conditions, we
knocked down HUWE1 in HeLa cells. Accumulation of H2AX
(4.4 ± 0.2-fold increase) was observed 72 hr after treatment
with small interfering RNA (siRNA) targeting HUWE1 (Figures
4E and S3D), suggesting that H2AX destabilization is mediated
by HUWE1. Together, these results illustrate that HUWE1 medi-
ates H2AX degradation through poly-ubiquitination and is
responsible for establishment of the H2AX-downregulated state
under normal cellular conditions.
The H2AX poly-ubiquitination mediated by HUWE1 under un-
damaged conditions is clearly distinct from the modification
catalyzed by RNF168 during DNA damage repair. In undamagedthors
Figure 4. H2AXNormally Undergoes Poly-ubiquitinationMediated by the E3 Ligase HUWE1, which Prevents Its Incorporation into Chromatin
(A and B) Separation of poly-ubiquitinated H2AX from non-ubiquitinated H2AX. As shown schematically (A, left), undamaged HeLa cells were lysed in PBS
containing 0.5% NP-40 and separated into supernatant and pellet fractions (A). IP with the supernatant (Sup.) fraction was performed using anti-H2AX (A and B)
and -ubiquitin antibodies (B). Signals around 100 kDa were cross-immunoprecipitated and immunoblotted using anti-H2AX and -ubiquitin antibodies (B). Non-
immune IgG was used as a negative control (NC-IgG).
(C and D) Formation of a complex comprising H2AX and the E3 ubiquitin ligase HUWE1. In liquid chromatography-mass spectrometry analysis using the 2DICAL
technique, the HUWE1 signal was much brighter in immunoprecipitates obtained using an anti-H2AX antibody than in those obtained using non-immune IgG
(NC-IgG) (C). The interaction between H2AX and HUWE1 was confirmed by IB (D).
(E) H2AX downregulation mediated by the E3 ubiquitin ligase HUWE1. HUWE1 was knocked down in HeLa cells using an siRNA (siHUWE1 1). H2AX accumulated
under undamaged conditions after HUWE1 KD. siNC indicates cells treated with negative control siRNA.
(F–H) Involvement of HUWE1 in DSB repair. The effect of HUWE1 KD (siHUWE1) on DSB repair was determined after g-ray irradiation (5 Gy) in HeLa cells. The
DNA damage status was determined by the decay of gH2AX and 53BP1 foci (F) and the gH2AX immunoblot signal (H). The H2AX status also was assessed. The
numbers of gH2AX foci shown in (F) are depicted in the graph shown in (G). siNC indicates cells treated with negative control siRNA. Error bars represent ± SD.
Scale bars, 10 mm.
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cells, poly-ubiquitinated H2AX was present at high levels in the
supernatant fraction (Figure S3B), whereas in damaged cells,
ubiquitinated H2AX and gH2AX were detected only in the pellet
(chromatin) fraction (Figure S3E).
HUWE1 Is Involved in DSB Repair
To investigate the involvement of HUWE1 in DSB repair, we
knocked down HUWE1 in HeLa cells and monitored the forma-
tion and decay of gH2AX and 53BP1 foci (Figures 4F–4H).
HUWE1-knockdown (KD) cells, in which the background level
of H2AX was increased, could still efficiently form gH2AX and
53BP1 foci in response to DSBs (Figures 4F and 4G, see at
1.5 hr), but the decay of gH2AX foci was slower. These observa-
tions demonstrate that HUWE1 is not required for the formation
of gH2AX and 53BP1 foci, at least when H2AX is expressed, but
is still necessary for efficient DSB repair. DSB-dependent H2AX
stabilization also was impaired by HUWE1 KD (Figure 4H); how-
ever, these cells still exhibited slight H2AX stabilization, which
implies that other pathways enable H2AX stabilization upon
DSB formation.
H2AX Stabilization upon DSB Formation Is Mediated
by ATM
How does DSB formation immediately block poly-ubiquitination
of H2AX? We investigated the involvement of the DNA damage
checkpoint response using an ATM inhibitor (KU55933) in
HeLa cells. As expected, cells treated with KU55933 exhibited
minimal H2AX stabilization (Figure 5A). Similarly, H2AX stabiliza-
tion and gH2AX expression were impaired in ATM-knockout (KO)
MEFs (Figure 5B). Thus, in addition to gH2AX foci formation,
ATM promotes H2AX stabilization in response to DSBs. As
with gH2AX foci formation, ATM is not the only factor that in-
duces H2AX stabilization; H2AX was stabilized following treat-
ment with a higher concentration of NCS even in ATM-KO cells,
concomitant with ATM-independent upregulation of gH2AX (Fig-
ure S4A). Such ATM-dependent H2AX stabilization is associated
with gH2AX foci enlargement (Figure 5C, see orange arrow-
heads), which is consistent with a previous study that showed
the failure of enlarged gH2AX foci formation in an ATM-deficient
background (Bonner et al., 2008). Although the H2AX level was
high in HUWE1-KD cells, gH2AX foci enlargement in the ATM-
deficient background was not recovered by HUWE1 KD (Fig-
ure S4B), suggesting the requirement of ATM for enlarged
gH2AX foci formation.
Next we investigated the association of ATM signals with the
halting of H2AX poly-ubiquitination by damage. Intriguingly,
HUWE1 dissociated from poly-ubiquitinated H2AX in response
to DSBs; co-immunoprecipitation (coIP) of these proteins with
anti-H2AX and -HUWE1 antibodieswas reduced after DNA dam-
age (Figure 5D, see red arrowheads). However, this DNA dam-
age-dependent complex dissociation was obstructed by an
ATM inhibitor (Figure 5E, see red open arrowheads). Similar re-
sults were observed in ATM-KO cells (Figure S4C). Thus, the
HUWE1/poly-ubiquitinated H2AX complex that is observed in
the undamaged state is ATM-dependently attenuated upon
DSB formation, in association with rapid H2AX stabilization
and the halt of H2AX degradation, enabling gH2AX foci
formation.2734 Cell Reports 13, 2728–2740, December 29, 2015 ª2015 The AuThe Ser139 Residue of H2AX Is Required for H2AX
Stabilization in Response to DSBs
The results described above indicate that activatedATMplays an
early role in H2AX stabilization by blockingH2AX poly-ubiquitina-
tion. Hence, we investigated whether the C-terminal region of
H2AX, which includes the Ser139 phosphorylation site, is
required for stabilization upon DNA damage. To this end, we em-
ployed chicken DT40 cells in which the endogenous H2AX gene
wasmutated inoneof twomannersas follows:C-terminal trunca-
tion from Ala135 (dC135) (H2AX/dC135) or substitution of Ser139
with alanine (S139A) (H2AX/S139A), using an anti-H2AX antibody
that weakly but specifically recognized S139A-H2AX. As in
mammalian cells, H2AX stabilization and gH2AX expression
were observed in response to DSBs in DT40 cells (Figure 6A),
but S139A-H2AX was not stabilized (Figures 6A and 6B, see
blue arrows). Although we failed to detect dC135-H2AX in this
experiment, this was expected because the H2AX region de-
tected by the antibody was lacking. These observations at least
imply that the Ser139 residue is responsible for H2AX stabiliza-
tion, as well as gH2AX foci formation, in response to DSBs.
To confirm the involvement of the H2AX C-terminal region in
H2AX stabilization in response to DSBs, we performed 2D acetic
acid-urea-triton (AUT)-SDS gel electrophoresis to separate
H2AX fromH2A and directly visualize the alteration in the balance
of H2AX/H2A in response toDSBs induced byg-ray irradiation (10
Gy). In response to DSB formation, the level of wild-type (WT)
H2AX protein increased significantly (Figure 6C, see red arrows),
whereas the level of S139A-H2AX did not. In addition, gH2AX
andmono-ubiquitinatedH2A/H2AXaccumulated inWTDT40cells
(Figure 6C, see blue arrows), but not in cells expressing S139A-
H2AX (Figures 6C and S5 for the close-up image, see blue open
arrowheads). In WT DT40 cells, the gH2AX signal was detected
as two bands, probably due to an additional modification that
causes faster migration by AUT-PAGE. These findings demon-
strate that the Ser139 residue is required for H2AX stabilization
and the subsequent repair-associated ubiquitination of H2A/
H2AX. Similarly, cells expressing dC135-H2AX did not exhibit a
change in the status of ubiquitinated H2A/dC135-H2AX in
response to DSBs (H2A and dC135-H2AX were not resolved by
this2Dgel system).Thus, theC-terminal regionofH2AX is required
for H2AX stabilization and subsequent repair-associated ubiquiti-
nation. In particular, the Ser139 residue is responsible for H2AX
stabilization upon DSB formation. In agreement with this conclu-
sion, unlike WT H2AX and FLAG-taggedWT H2AX, FLAG-tagged
S139A-H2AX was not stabilized by NCS treatment (Figure 6D).
Initial H2AX Stabilization Is Dependent on SIRT6/SNF2H
The above results illustrated that ATMmediates rapid H2AX sta-
bilization upon DSB formation to enable efficient gH2AX foci for-
mation. This process underlies the rapid chromatin incorporation
of H2AX, posing the question of how the chromatin incorporation
of H2AX in response to DSBs is regulated. It was shown recently
that SNF2H, the catalytic subunit of ISWI chromatin-remodeling
complexes, is SIRT6-dependently recruited to damaged sites in
chromatin (Toiber et al., 2013). In fluorescence time-lapse ana-
lyses using GFP-fusion proteins, SNF2H rapidly was recruited
to DSB sites, which was followed by H2AX accumulation (Min
et al., 2014).thors
Figure 5. H2AX Is Stabilized in Response to DSBs through ATMActivation with the Resulting Attenuation of the Poly-ubiquitinated H2AX and
HUWE1 Complex
(A and B) Involvement of ATM in H2AX stabilization. HeLa cells pretreated with an ATM inhibitor (KU55933) were deficient in transient H2AX stabilization in
response to DSBs, as illustrated by western blotting (A). The H2AX/gH2AX induction status also was assessed in ATM-KO MEFs (B).
(C) ATM-dependent enlargement of gH2AX foci in response to DSBs. The effects of gH2AX foci formation were compared in ATM-WT and -KOMEFs at 5min and
1 hr after NCS treatment. Orange arrowheads represent the enlarged gH2AX foci. Scale bars, 10 mm.
(D) Dissociation of HUWE1 from poly-ubiquitinated H2AX in response to DSBs. HeLa cells were treated with 50 ng/ml NCS. The change in the efficiency of coIP
using anti-HUWE1 and -H2AX antibodies was determined by comparing the co-immunoprecipitated signals before and after NCS treatment. Red arrowheads
indicate the attenuated coIP signals.
(E) ATM-mediated attenuation of the HUWE1/poly-ubiquitinated H2AX complex after DNA damage. HeLa cells treated as in (A) were immunoprecipitated as in
(D). The effect of an ATM inhibitor on coIP was assessed. Red closed arrowheads indicate the attenuated coIP signals. Red open arrowheads indicate the failure
of such attenuation. The levels of poly-ubiquitinated H2AX were quantitated; the ratio relative to the signal prior to NCS treatment was defined as 1. Data were
normalized against HUWE1. Error bars represent ± SD.This motivated us to test the involvement of SIRT6/SNF2H in
the chromatin incorporation of H2AX in response to DSBs (Fig-
ures 7A and 7B). As expected, H2AX stabilization was largely
impaired by KD of SIRT6 and SNF2H at 15 min after g-ray irradi-
ation (Figure 7B), which was associated with an impairment inCell RepgH2AX foci formation at 5–30 min after g-ray irradiation
(Figure 7A). In fact, more H2AX was immunoprecipitated with
histones H3 and H2AZ after damage (Figure 7C). Although
SIRT6- and SNF2H-KD cells still exhibited the late onset of
gH2AX foci formation at 1 hr after g-ray irradiation (Figure S6A),orts 13, 2728–2740, December 29, 2015 ª2015 The Authors 2735
Figure 6. The C-terminal H2AX Region Is Required for the Stabilization of H2AX by DSBs
(A–C) Requirement of the C-terminal region of H2AX for stabilization by DSBs. Damage-dependent H2AX stabilization was determined in chicken DT40 cells
expressing S139A-H2AX, which was detected by an anti-H2AX antibody that weakly recognizes S139A-H2AX (A and B, see blue arrows), but not dC135-H2AX
(A, SDS-PAGE and B, AUT-PAGE). The requirement of the H2AX C-terminal region for H2AX stabilization by DSBs was further assessed by 2D (AUT-SDS) gel
electrophoresis (C), in which whole-histone extracts were loaded and visualized by Flamingo staining (to detect total protein) and by western blotting (to detect
H2AX and gH2AX). Cells before and 1 hr after g-ray irradiation (10 Gy) were compared directly. Histone extracts from 5 3 107 and 2 3 107 cells were used for
Flamingo staining and western blotting, respectively. Ub-H2A(X)/gH2AX indicates mono-ubiquitinated H2A(X)/gH2AX. H2AX/gH2AX and Ub-H2A(X)/Ub-gH2AX
signals are indicated by green and blue circles, respectively. See also Figure S5.
(D) The Ser139 residue is required for H2AX stabilization upon DSB formation. FLAG-taggedWT and S139A H2AX-expressing vectors were transfected into HeLa
cells. Signals of H2AX and FLAG-tagged H2AX are indicated. NC indicates cells transfected with a negative control vector. Blue and red arrowheads indicate the
stabilized H2AX and FLAG-tagged H2AX (WT) by g-ray, respectively. Red open arrowheads indicate FLAG-tagged H2AX (139A) signal in damaged cells.these results indicate that SIRT6 and SNF2H are required for
rapid H2AX stabilization uponDSB formation to efficiently induce
gH2AX foci. This pronounced role in the rapid response is similar
to that of ATM (Figure S6B). Importantly, H2AX accumulation in
SIRT6-KD cells at 1 hr after g-ray irradiation was observed2736 Cell Reports 13, 2728–2740, December 29, 2015 ª2015 The Aumainly outside chromatin (Figure S6C, see closed and open
red arrowheads), supporting the SIRT6 dependence for chro-
matin incorporation of H2AX. Thus, these results illustrate the
involvement of SIRT6/SNF2H for H2AX stabilization and the
chromatin incorporation upon DSB formation.thors
Figure 7. SIRT6 and SNF2H Facilitate H2AX Stabilization upon DSB Formation and Its Introduction into Chromatin under the Regulation
of ATM
(A and B) Involvement of SIRT6 and SNF2H in H2AX stabilization. HeLa cells in which SIRT6 and SNF2H were knocked down were deficient in H2AX stabilization
and gH2AX foci formation upon DSB formation, as illustrated by immunostaining 5–30 min after (A) and western blotting 15 min after (B) g-ray irradiation (10 Gy).
Error bars represent ± SD. Scale bars, 20 mm.
(C) Chromatin incorporation of stabilized H2AX upon DSB formation. Cells were fractionated into chromatin fraction and chromatin unbound fractions. Immu-
noprecipitates of anti-H2AX antibodies were immunoblotted with the indicated antibodies.
(D) Schematic representation of DSB repair in growth-arrested normal cells mediated by transient H2AX stabilization. (a) Growth-arrested normal cells generally
enter a quiescent state with downregulated H2AX, during which time H2AX is continuously produced but degraded via poly-ubiquitination mediated by HUWE1.
(b) Immediately after DSB formation, non-ubiquitinated H2AX is incorporated into chromatin under the regulation of SNF2H, the catalytic subunit of ISWI
chromatin-remodeling complexes, and ATM kinase, enabling efficient gH2AX foci formation and DSB repair. (c) Once DSBs are repaired, cells return to a growth-
arrested state with downregulated H2AX.DISCUSSION
Growth-arrested normal cells that rarely express H2AX can effi-
ciently form gH2AX foci upon DSB formation, via transient stabi-
lization of H2AX, and hence effectively induce repair (Figure 7D),
unlike H2AX-KO cells. After DSBs are repaired, cellular H2AX re-
verts to its original low level. This conclusion is supported by theCell Repfollowing data: (1) even when H2AX is present at low levels, as in
quiescence, cells efficiently form gH2AX foci in response to
DSBs via transient stabilization of H2AX; (2) H2AX is continuously
expressed, but under normal conditions it is poly-ubiquitinated
by the E3 ubiquitin ligase HUWE1 and degraded, limiting the
cellular level of H2AX; (3) degradation of H2AX is transiently
halted in response to DSBs, mediated by the ATM kinase; (4)orts 13, 2728–2740, December 29, 2015 ª2015 The Authors 2737
H2AX stabilization upon DSB formation is associated with its
chromatin incorporation regulated by SIRT6 and SNF2H, during
which HUWE1 dissociates from ubiquitinated H2AX; and (5)
Ser139, the ATM phosphorylation site in H2AX, is required for
the stabilization of H2AX.
H2AXUpregulation uponDSB Formation and Statuses of
H2AZ and macroH2A.1
H2AX stabilization upon DSB formation also is observed in trans-
formed cells. The generality of H2AX stabilization during DSB
repair raises a question: given that gH2AX foci have been moni-
tored extensively over a decade of DNA damage studies, how
was such an important facet of H2AX/gH2AX regulation missed?
This mode of regulation was likely difficult to identify for the
following several reasons: (1) most DNA damage studies were
performed using transformed cells that contain higher back-
ground levels of H2AX, in which the H2AX level is altered much
less than the gH2AX signal; (2) unlike the change in the H2AX
protein level, the H2AX transcript level barely changes in
response to DSBs; (3) some commercially available anti-H2AX
antibodies are not specific to H2AX and show quite a high affinity
for H2A (Figures S7A and S7B), making it difficult to determine
the real H2AX level because H2A is much more abundant than
H2AX and is not easily separated from H2AX by SDS-PAGE;
and (4) the recognition of H2AX by specific antibodies seems
to be often affected by modifications, such as phosphorylation
of Ser139 (Figures S7C and S7D); therefore, it might be neces-
sary to dephosphorylate H2AX before IB to determine the real
H2AX status with such antibodies.
In association with H2AX stabilization upon DSB formation, we
also observed increases in the levels of the histone H2A variants
H2AZ and macroH2A.1 in quiescent cells (Figure S7C), as
recently reported in HeLa cells (Xu et al., 2012a, 2012b). We do
not know how these variants are regulated and if they are upre-
gulated in cooperation with H2AX stabilization in response to
DNA damage.
Regulation of Cellular H2AX Levels
H2AX is required for active cell growth and efficient DNAdamage
response; therefore, these activities are altered by changes in
the cellular H2AX level. H2AX levels are regulated by multiple
mechanisms, including transcriptional regulation and regulation
by microRNAs (Lal et al., 2009; Wang et al., 2011). The mecha-
nism revealed in this study represents a distinct means of
H2AX regulation, in which H2AX levels remain low under normal
conditions but rapidly increase upon DSB formation.
The cellular H2AX level also is regulated by the ARF/p53 mod-
ule, although the underlying mechanism remains unclear. After
serial proliferation, differentiated normal cells generally enter a
growth-arrested state with downregulated H2AX under the con-
trol of the ARF/p53 module, which is associated with the protec-
tion of cells from immortalization (Atsumi et al., 2011, 2013;
Osawa et al., 2013). Therefore, H2AX levels in normal growth-ar-
rested cells are simultaneously regulated by multiple me-
chanisms that involve the ARF/p53 module and proteasomal
degradation. Although our study identified HUWE1 as a respon-
sible E3 ligase for H2AX degradation, HUWE1 might not be the
only E3 ligase that mediates H2AX degradation.2738 Cell Reports 13, 2728–2740, December 29, 2015 ª2015 The AuContributions of ATM, SIRT6, and SNF2H to H2AX
Stabilization Regulation
How is H2AX stabilized in response to DSBs? Our data indicated
the involvement of immediate chromatin incorporation (Figure 7).
Such chromatin incorporation of H2AX is mediated by the ISWI
family chromatin-remodeling factor SNF2H and the sirtuin pro-
tein SIRT6, at least for the immediate response to DSBs. Both
SNF2H and SIRT6 are involved inmultiple aspects of damage re-
sponses; therefore, chromatin incorporation of H2AX is probably
not the only contribution to gH2AX foci formation and resulting
repair. The chromatin remodeler Rsf-1, which interacts with
SNF2H, is ATM-dependently recruited to DSB sites (Min et al.,
2014). Activated ATMmight directly signal to SNF2H/Rsf-1 in or-
der to initiate H2AX incorporation into chromatin at sites close to
DSBs under the regulation of SIRT6. Simultaneously, HUWE1
also could be directly regulated by ATM because HUWE1 is a
potential target of ATM (Matsuoka et al., 2007), and we observed
ATM-dependent dissociation of HUWE1 from poly-ubiquitinated
H2AX (Figure 5E).
Biological Effects of H2AX Downregulation and
Transient Stabilization
Themechanism that enables rapid H2AX stabilization (i.e., termi-
nation of its poly-ubiquitination and degradation) is similar to the
mechanisms that are required for rapid responses to certain
stresses but are toxic under most other conditions, e.g., Nrf2,
which is expressed in response to oxidative stress (Kobayashi
et al., 2004). This raises a question regarding the toxicity of
H2AX expression under normal conditions, especially in a
growth-arrested state. Such toxicity may be associated with
the promotion of cell-cycle progression by H2AX and resulting
genomic destabilization. Indeed, exogenous H2AX expression
in MEFs promotes genomic destabilization and consequently re-
sults in accelerated acquisition of immortality (Atsumi et al.,
2011). By contrast, H2AX downregulation directly induces a
growth-arrested state, as observed in H2AX-KD cells (Atsumi
et al., 2011, 2013). Thus, several lines of evidence suggest that
cells are protected from transformation under theH2AX-downre-
gulated state. In fact, although H2AX expression usually re-
covers in transformed cells, H2AX is widely downregulated in
normal growth-arrested cells in vivo and in vitro, which are
continuously protected from transformation (Atsumi et al., 2011).
Although normal cells in vivo and in vitro are generally growth
arrested with downregulated H2AX, H2AX is still required for
DSB repair. Therefore, growth-arrested cells with significantly
reduced H2AX levels defend themselves against DSBs through
transient H2AX stabilization and subsequent repair. This
pathway relies on continuous H2AX production and degradation




WT MEFs were prepared as previously described and cultured using a stan-
dard 3T3 passage protocol (Todaro and Green, 1963) or a modified protocol
(tSD-3T3) to generate quiescent MEFs (passage 8) (Atsumi et al., 2011).
ATM-KOMEFswere prepared in the ARF-KObackground andwere compared
with ARF-KOMEFs. DT40 cells were cultured as previously described (Sonodathors
et al., 2007). HeLa cells and normal human fibroblast cells WI-38 (RIKEN) were
cultured as previously described (Atsumi et al., 2011).
DNA Damage
DNAdamagewas induced by treatment with NCS (Sigma) and HU (Sigma) and
by 137Cs irradiation in a Gammacell 40 Exactor (Best Theratronics) and UV illu-
minator (Stratagene).
Immunostaining, Western Blotting, IP, and 2DICAL Analysis
Western blot analysis was performed as previously described (Ichijima et al.,
2010). To determine the un-ubiquitinated H2AX status, all western blot ana-
lyses were performed with fresh samples obtained from DNA damage exper-
iments. Immunostaining was performed as previously described (Atsumi
et al., 2011), using a confocal laser microscope (Olympus FV10i). IP in Fig-
ures 4 and 5 was performed as previously described (Yoshioka et al.,
2006), using protein A magnetic beads (Tamagawa-Seiki) in the presence
of a complete protease inhibitor cocktail (Roche). IP in Figure 7 was per-
formed as previously described (Yata et al., 2012) in the presence of Benzo-
nase Nuclease (Millipore).
The 2DICAL sampleswere eluted from immunoprecipitated beads by boiling
in 1% sodium deoxycholate for 10min. The 2DICAL analysis was performed as
previously described (Fukawa et al., 2012; Ono et al., 2006).
AUT and 2D Gel Electrophoreses
Histone extract fractions were prepared as previously described (Bonner et al.,
1980) from chromatin fractionated as described in Figure 5A. AUT gel electro-
phoresis was performed as previously described (Bonner et al., 1980). For 2D
(AUT-SDS) gels, AUT gel electrophoresis was performed for the first dimen-
sion. The AUT gel strips were pre-equilibrated with lithium dodecyl sulfate
(LDS) buffer (Life Technologies) and applied to SDS-PAGE for the second
dimension. The H2AX status was detected by Flamingo staining (Bio-Rad) or
western blotting.
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